Evidence map›Paper›PMID 22031535›Full record

ArticleCytoskeleton (Hoboken, N.J.)2011

Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion.

Lilly Y W Bourguignon, Gabriel Wong, Christine A Earle, Weiliang Xia

Abstract read
In one paragraph

Article in Cytoskeleton (Hoboken, N.J.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 118 citations in OpenAlex.

  1. Plant-DerivedNutrients · 2021
    Trial
  2. Article
  3. Article
  4. Review
  5. Metastasis-promoting functions of myeloid cells.Cancer metastasis reviews · 2025
    Review
  6. Implication of Immunobiological Function of Melanocytes in Dermatology.Clinical reviews in allergy & immunology · 2025
    Review
  7. Article
  8. Review
  9. Biodegradable scaffolds for enhancing vaccine delivery.Bioengineering & translational medicine · 2023
    Article
  10. The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer.International journal of molecular sciences · 2023
    Review
  11. International journal of molecular sciences · 2023
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Hyaluronic Acid as a Modern Approach in Anticancer Therapy-Review.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Lilly Y W BourguignonDepartment of Medicine, University of California, San Francisco, USA. lilly.bourguignon@ucsf.edu
Gabriel Wong
Christine A Earle
Weiliang Xia
University of California, San Francisco · US

Funding

RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTIONP01AR039448 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1988 to 2007
$11.8M
CD44/VARIANT CYTOSKELETON IN BREAST CANCER PROGRESSIONR01CA066163 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BOURGUIGNON, LILLY YW · 1995 to 2010
$2.6M
CD44-P185HER2 INTERACTION IN OVARIAN CANCER PROGRESSIONR01CA078633 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BOURGUIGNON, LILLY YW · 1999 to 2007
$2.5M
NCI NIH HHS R01 CA066163NCI NIH HHS R01 CA078633NCI NIH HHS R01 CA66163NCI NIH HHS R01 CA78633NIAMS NIH HHS P01 AR039448NIAMS NIH HHS P01 AR39448
6 · The paper itself

Abstract

Both high and low molecular weight hyaluronan (HMW-HA vs. LMW-HA) exist in various tissues and cells. In this study, we investigated LMW-HA-mediated CD44 interaction with Toll-like receptors (TLRs), the actin filament-associated protein (AFAP-110), and a myeloid differentiation factor (MyD88) in breast tumor cells (MDA-MB-231 cells). Our data indicate that LMW-HA (but not HMW-HA) preferentially stimulates a physical association between CD44 and TLRs followed by a concomitant recruitment of AFAP-110 and MyD88 into receptor-containing complexes in breast tumor cells. LMW-HA-activated AFAP-110 then binds to filamentous actin (F-actin) resulting in MyD88/nuclear factor-κB (NF-κB) nuclear translocation, NF-κB-specific transcription, and target gene [interleukine 1β and interleukine-8 (IL-1β and IL-8)] expression. These signaling events lead to proinflammatory cytokine/chemokine production in the breast tumor cells. AFAP-110-F-actin (activated by LMW-HA) also promotes tumor cell invasion. Downregulation of AFAP-110 or MyD88 by transfecting breast tumor cells with AFAP-110 siRNA or MyD88 siRNA, respectively not only blocks the ability of LMW-HA to stimulate AFAP-110-actin function, but also impairs MyD88-NF-κB nuclear translocation and NF-κB transcriptional activation. Consequently, both IL-1β/IL-8 production and tumor cell invasion are impaired. Taken together, these findings suggest that LMW-HA plays an important role in CD44-TLR-associated AFAP-110-actin interaction and MyD88-NF-κB signaling required for tumor cell behaviors, which may contribute to the progression of breast cancer.

Indexed as

AnimalsBreast NeoplasmsCell Line, TumorCell MovementChemokinesCytokinesFemaleHumansHyaluronan ReceptorsHyaluronic AcidMicrofilament ProteinsNF-kappa BPhosphoproteinsRatsRNA, Small InterferingSignal TransductionAFAP 110ChemokinesCytokinesHyaluronan ReceptorsHyaluronic AcidMicrofilament ProteinsNF-kappa BPhosphoproteinsRNA, Small Interfering

Identifiers

PMID22031535
PMCPMC3240717
OpenAlexW2033403956

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.